Arginine metabolism demonstrates significant potential in tumor immunoregulation, particularly through ASS1 downregulation-mediated arginine deprivation therapy (ADT) and its impact on T cell function as well as the expansion of MDSCs and Tregs. Here, ASS1 is linked to neoplasm.